Modulatory profiling identifies mechanisms of small molecule-induced cell death

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 39, 2011, Pages

  Wolpaw, Adam J ^a   Shimada, Kenichi ^a   Skouta, Rachid ^a   Welsch, Matthew E ^a   Akavia, Uri David ^a   Péer, Dana ^a   Shaika, Fatima ^a   Bulinski, J Chloe ^a   Stockwell, Brent R ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Apoptosis; Chemical biology; Small molecules

Indexed keywords

PROTEINASE; REACTIVE OXYGEN METABOLITE;

ARTICLE; CALCIUM SIGNALING; CELL DEATH; CHEMICAL STRUCTURE; GENE EXPRESSION; HUMAN; HUMAN CELL; LETHALITY; MODULATORY PROFILING; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-2-ASSOCIATED X PROTEIN; CELL DEATH; CELL LINE; HUMANS; MICROTUBULES; SIGNAL TRANSDUCTION;

MAMMALIA;

EID: 80053638991     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1106149108     Document Type: Article

References (66)

1. Wyllie AH (1981) Cell death: A new classification separating apoptosis from necrosis. Cell Death in Biology and Pathology, eds Bowen ID, Lockshin RA (Chapman & Hall, London), pp 9-34.
2. Kerr JF, Wyllie AH, Currie AR (1972) Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239-257.
3. Dive C, et al. (1992) Analysis and discrimination of necrosis and apoptosis (programmed cell death) by multiparameter flow cytometry. Biochim Biophys Acta 1133:275-285.
4. Duvall E, Wyllie AH (1986) Death and the cell. Immunol Today 7:115-119. (Pubitemid 17022305)
5. Taylor RC, Cullen SP, Martin SJ (2008) Apoptosis: Controlled demolition at the cellular level. Nat Rev Mol Cell Biol 9:231-241. (Pubitemid 351301823)
6. Vercammen D, et al. (1998) Dual signaling of the Fas receptor: Initiation of both apoptotic and necrotic cell death pathways. J Exp Med 188:919-930. (Pubitemid 28433418)
7. Degterev A, et al. (2005) Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 1:112-119.
8. Degterev A, et al. (2008) Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol 4:313-321. (Pubitemid 351550892)
9. Hitomi J, et al. (2008) Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell 135:1311-1323.
10. Cho YS, et al. (2009) Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 137:1112-1123.
11. He S, et al. (2009) Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 137:1100-1111.
12. Zhang DW, et al. (2009) RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 325:332-336.
13. Ha HC, Snyder SH (1999) Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc Natl Acad Sci USA 96:13978-13982.
14. Zong WX, Ditsworth D, Bauer DE, Wang ZQ, Thompson CB (2004) Alkylating DNA damage stimulates a regulated form of necrotic cell death. Genes Dev 18:1272-1282. (Pubitemid 38720595)
15. Yu SW, et al. (2002) Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 297:259-263.
16. Luke CJ, et al. (2007) An intracellular serpin regulates necrosis by inhibiting the induction and sequelae of lysosomal injury. Cell 130:1108-1119. (Pubitemid 47422305)
17. Syntichaki P, Xu K, Driscoll M, Tavernarakis N (2002) Specific aspartyl and calpain proteases are required for neurodegeneration in C. elegans. Nature 419:939-944. (Pubitemid 35339629)
18. Berry DL, Baehrecke EH (2007) Growth arrest and autophagy are required for salivary gland cell degradation in Drosophila. Cell 131:1137-1148. (Pubitemid 350235023)
19. Hofius D, et al. (2009) Autophagic components contribute to hypersensitive cell death in Arabidopsis. Cell 137:773-783.
20. Shimizu S, et al. (2004) Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nat Cell Biol 6:1221-1228. (Pubitemid 39625121)
21. Yu L, et al. (2004) Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science 304:1500-1502. (Pubitemid 38720930)
22. Kroemer G, et al. (2008) Classification of cell death: Recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ 16:3-11.
23. Fink SL, Cookson BT (2005) Apoptosis, pyroptosis, and necrosis: Mechanistic description of dead and dying eukaryotic cells. Infect Immun 73:1907-1916. (Pubitemid 40470787)
24. Bredesen DE (2007) Key note lecture: Toward a mechanistic taxonomy for cell death programs. Stroke 38(Suppl):652-660. (Pubitemid 46184235)
25. Fang J, Koen YM, Hanzlik RP (2009) Bioinformatic analysis of xenobiotic reactive metabolite target proteins and their interacting partners. BMC Chem Biol 9:5.
26. Feng BY, et al. (2008) Small-molecule aggregates inhibit amyloid polymerization. Nat Chem Biol 4:197-199. (Pubitemid 351264126)
27. Jackson JK, et al. (1994) A comparison of the lytic properties of two ether-linked lipids, one with and one without antineoplastic activity. Biochem Cell Biol 72:297-303.
28. Wong HL, Liebler DC (2008) Mitochondrial protein targets of thiol-reactive electrophiles. Chem Res Toxicol 21:796-804. (Pubitemid 351644557)
29. McGovern SL, Caselli E, Grigorieff N, Shoichet BK (2002) A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening. J Med Chem 45:1712-1722. (Pubitemid 34293537)
30. McGovern SL, Helfand BT, Feng B, Shoichet BK (2003) A specific mechanism of nonspecific inhibition. J Med Chem 46:4265-4272. (Pubitemid 37153008)
31. Coan KE, Shoichet BK (2007) Stability and equilibria of promiscuous aggregates in high protein milieus. Mol Biosyst 3:208-213. (Pubitemid 46293327)
32. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46:3-26. (Pubitemid 33653411)
33. Brinkley BR, Barham SS, Barranco SC, Fuller GM (1974) Rotenone inhibition of spindle microtubule assembly in mammalian cells. Exp Cell Res 85:41-46.
34. Marshall LE, Himes RH (1978) Rotenone inhibition of tubulin self-assembly. Biochim Biophys Acta 543:590-594. (Pubitemid 9043433)
35. Hughes TR, et al. (2000) Functional discovery via a compendium of expression profiles. Cell 102:109-126.
36. Waring JF, et al. (2001) Clustering of hepatotoxins based on mechanism of toxicity using gene expression profiles. Toxicol Appl Pharmacol 175:28-42. (Pubitemid 32783533)
37. Lamb J, et al. (2006) The Connectivity Map: Using gene-expression signatures to connect small molecules, genes, and disease. Science 313:1929-1935. (Pubitemid 44497995)
38. Boshoff HI, et al. (2004) The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism: Novel insights into drug mechanisms of action. J Biol Chem 279:40174-40184. (Pubitemid 39258293)
39. Iorio F, et al. (2010) Discovery of drug mode of action and drug repositioning from transcriptional responses. Proc Natl Acad Sci USA 107:14621-14626.
40. Dolma S, Lessnick SL, Hahn WC, Stockwell BR (2003) Identification of genotypeselective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell 3:285-296. (Pubitemid 37443883)
41. Yagoda N, et al. (2007) RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature 447:864-868. (Pubitemid 46920135)
42. Yang WS, Stockwell BR (2008) Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. Chem Biol 15:234-245. (Pubitemid 351391983)
43. Oprea TI (2000) Property distribution of drug-related chemical databases. J Comput Aided Mol Des 14:251-264.
44. Ghosh PB, Whitehouse MW (1968) 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole: A new fluorigenic reagent for amino acids and other amines. Biochem J 108:155-156.
45. Anwair MA, et al. (2003) Lipophilicity of aminopyridazinone regioisomers. J Agric Food Chem 51:5262-5270.
46. Stockwell BR (2004) Exploring biology with small organic molecules. Nature 432: 846-854.
47. Tait SW, Green DR (2008) Caspase-independent cell death: Leaving the set without the final cut. Oncogene 27:6452-6461.
48. Youle RJ, Karbowski M (2005) Mitochondrial fission in apoptosis. Nat Rev Mol Cell Biol 6:657-663. (Pubitemid 41081269)
49. De Vos KJ, Allan VJ, Grierson AJ, Sheetz MP (2005) Mitochondrial function and actin regulate dynamin-related protein 1-dependent mitochondrial fission. Curr Biol 15: 678-683.
50. Feng Y, Mitchison TJ, Bender A, Young DW, Tallarico JA (2009) Multi-parameter phenotypic profiling: Using cellular effects to characterize small-molecule compounds. Nat Rev Drug Discov 8:567-578.
51. Chen Y, et al. (2008) Variations in DNA elucidate molecular networks that cause disease. Nature 452:429-435. (Pubitemid 351450844)
52. Basso K, et al. (2005) Reverse engineering of regulatory networks in human B cells. Nat Genet 37:382-390.
53. Lim WK, Lyashenko E, Califano A (2009) Master regulators used as breast cancer metastasis classifier. Pac Symp Biocomput 2009:504-515.
54. Keiser MJ, et al. (2009) Predicting new molecular targets for known drugs. Nature 462:175-181.
55. Campillos M, Kuhn M, Gavin AC, Jensen LJ, Bork P (2008) Drug target identification using side-effect similarity. Science 321:263-266. (Pubitemid 351989100)
56. Lindahl PE, Oberg KE (1960) Mechanism of the physiological action of rotenone. Nature 187:784.
57. Farha MA, Brown ED (2010) Chemical probes of Escherichia coli uncovered through chemical-chemical interaction profiling with compounds of known biological activity. Chem Biol 17:852-862.
58. Yeh P, Tschumi AI, Kishony R (2006) Functional classification of drugs by properties of their pairwise interactions. Nat Genet 38:489-494.
59. Parsons AB, et al. (2004) Integration of chemical-genetic and genetic interaction data links bioactive compounds to cellular target pathways. Nat Biotechnol 22:62-69. (Pubitemid 38057958)
60. Parsons AB, et al. (2006) Exploring the mode-of-action of bioactive compounds by chemical-genetic profiling in yeast. Cell 126:611-625. (Pubitemid 44163601)
61. Paull KD, et al. (1989) Display and analysis of patterns of differential activity of drugs against human tumor cell lines: Development of mean graph and COMPARE algorithm. J Natl Cancer Inst 81:1088-1092. (Pubitemid 19175145)
62. Weinstein JN, et al. (1997) An information-intensive approach to the molecular pharmacology of cancer. Science 275:343-349. (Pubitemid 27051604)
63. Jiang H, Pritchard JR, Williams RT, Lauffenburger DA, Hemann MT (2011) A mammalian functional-genetic approach to characterizing cancer therapeutics. Nat Chem Biol 7:92-100.
64. Nociari MM, Shalev A, Benias P, Russo C (1998) A novel one-step, highly sensitive fluorometric assay to evaluate cell-mediated cytotoxicity. J Immunol Methods 213: 157-167. (Pubitemid 28332808)
65. Hamid R, Rotshteyn Y, Rabadi L, Parikh R, Bullock P (2004) Comparison of alamar blue and MTT assays for high through-put screening. Toxicol In Vitro 18:703-710. (Pubitemid 38900879)
66. Hubbell E, Liu WM, Mei R (2002) Robust estimators for expression analysis. Bioinformatics 18:1585-1592. (Pubitemid 36097723)